Literature DB >> 36118394

Gastric Mucormycosis Masquerading as Gastric Malignancy.

K Suhaildeen1, Urmila Majhi2, Ramakrishnan Ayloor Seshadri1, Kanchan Murhekar2.   

Abstract

Mucormycosis is an opportunistic fungal infection usually seen in immunocompromised patients. We report a case of gastric mucormycosis in an immune-competent lady that mimicked a gastric malignancy, presenting a diagnostic challenge. A high index of suspicion is required for the diagnosis and successful treatment of this potentially life-threatening condition. © Indian Association of Surgical Oncology 2016.

Entities:  

Keywords:  Gastric cancer; Gastric lymphoma; Mucormycosis; Surgery

Year:  2016        PMID： 36118394      PMCID： PMC9478046          DOI： 10.1007/s13193-016-0554-9

Source DB:  PubMed          Journal:  Indian J Surg Oncol        ISSN： 0975-7651


  19 in total

1.  Gastric mucormycosis.

Authors:  Young Sook Park; Jung Don Lee; Tae Hun Kim; Yeon Ho Joo; Jin Hyuk Lee; Tae Seok Lee; Eun Kyung Kim
Journal:  Gastrointest Endosc       Date:  2002-12       Impact factor: 9.427

2.  Localized cecal zygomycosis following renal transplantation.

Authors:  A Echo; R V Hovsepian; G K Shen
Journal:  Transpl Infect Dis       Date:  2005-06       Impact factor: 2.228

3.  Repeating gastric biopsy for accuracy of gastric lymphoma diagnosis.

Authors:  Weihua Xu; Chengjun Zhou; Gangfeng Zhang; Hongbo Wang; Li Wang; Jianqiang Guo
Journal:  Gastroenterol Nurs       Date:  2010 Jul-Aug       Impact factor: 0.978

Review 4.  Epidemiology and outcome of zygomycosis: a review of 929 reported cases.

Authors:  Maureen M Roden; Theoklis E Zaoutis; Wendy L Buchanan; Tena A Knudsen; Tatyana A Sarkisova; Robert L Schaufele; Michael Sein; Tin Sein; Christine C Chiou; Jaclyn H Chu; Dimitrios P Kontoyiannis; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2005-07-29       Impact factor: 9.079

5.  Gastric mucormycosis.

Authors:  M H Ismail; H J Hodkinson; G Setzen; C Sofianos; M J Hale
Journal:  Trop Gastroenterol       Date:  1990 Apr-Jun

6.  Mucormycosis in patients without cancer: a case series from A tertiary care hospital in South India.

Authors:  A Ghafur; P S Shareek; Nambi P Senthur; P R Vidyalakshmi; V Ramasubramanian; Ashok Parameswaran; M A Thirunarayan; R Gopalakrishnan
Journal:  J Assoc Physicians India       Date:  2013-05

7.  Recent advances in the treatment of mucormycosis.

Authors:  Brad Spellberg; Ashraf S Ibrahim
Journal:  Curr Infect Dis Rep       Date:  2010-11       Impact factor: 3.725

8.  Delaying amphotericin B-based frontline therapy significantly increases mortality among patients with hematologic malignancy who have zygomycosis.

Authors:  Georgios Chamilos; Russell E Lewis; Dimitrios P Kontoyiannis
Journal:  Clin Infect Dis       Date:  2008-08-15       Impact factor: 9.079

9.  Mucormycosis: ten-year experience at a tertiary-care center in Greece.

Authors:  G Petrikkos; A Skiada; H Sambatakou; A Toskas; G Vaiopoulos; M Giannopoulou; N Katsilambros
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-06       Impact factor: 3.267

Review 10.  Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment.

Authors:  R M Prabhu; R Patel
Journal:  Clin Microbiol Infect       Date:  2004-03       Impact factor: 8.067
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.